• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthpublic health

These Opioids Are Killing an Increasing Number of American Teens

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
August 16, 2017, 5:27 PM ET
Macro of oxycodone opioid tablets
Oxycodone is the generic name for a range of opoid pain killing tablets. Prescription bottle for Oxycodone tablets and pills on wooden table for opioid epidemic illustration. Backyard Production/Getty Images/iStockphotoBackyard Production/Getty Images/iStockphoto

The U.S. Opioid crisis, recently declared a national emergency by President Donald Trump, is claiming the lives of an increasing number of American youths.

A new report from the Centers for Disease Control (CDC) finds that overdose deaths among 15-to-19 year olds spiked more than 19% between 2014 and 2015. Prior to the increase, the death rate from drug overdoses actually fell 26% from 2007 to 2014.

Click hereto subscribe to Brainstorm Health Daily, our brand new newsletter about health innovations.

The vast majority of these deaths, 80% were accidental whereas 13.5% were suicides. And opioids, which are powerful painkillers that can be highly addictive, were involved in the bulk of cases (65%) in 2015—but certain types of opioids like the synthetic drug fentanyl and heroin were much more likely killers than natural or semisynthetic opioids were.

CDC
CDC

Fentanyl especially has become a major cause for public health concern because of its sheer potency. Some versions of the synthetic drug can cause an overdose with just 3 grams of product; a comparable overdose-level of heroin may be about 30 milligrams, or ten times as much.

[Tempo-video id=”5538629039001″ account_id=”2111767321001″ autoplay=true]

In 2015, more than 33,000 American deaths were tied to opioids in one way or another, according to the CDC. The crisis has led to major backlash against both doctors who hand out prescriptions too easily and drug makers and distributors who aggressively market products like OxyContin. On Wednesday, South Carolina became the latest state to sue OxyContin manufacturer Purdue Pharma over marketing practices.

“The opioid crisis is an emergency and I’m saying officially right now it is an emergency,” Trump told reporters earlier this month. “We’re going to draw it up and we’re going to make it a national emergency. It is a serious problem, the likes of which we have never had.” Trump also recommended a “just-say-no” policy which some experts say would likely be ineffective.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.